Details

Autor(en) / Beteiligte

• Marchetti, C
• Mele, MC
• Rinninella, E
• Cintoni, M
• Raoul, P
• Scaletta, G
• Gasbarrini, A
• Scambia, G
• Fagotti, A

Titel

EP1227 Nutritional interventions to improve clinical outcomes in ovarian cancer: a systematic review of randomized controlled trials

Ist Teil von

• International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A51-A51

Ort / Verlag

Oxford: BMJ Publishing Group LTD

Erscheinungsjahr

2019

Beschreibungen/Notizen

• Introduction/BackgroundAmong all gynaecological neoplasms, ovarian cancer has the highest rate of disease-related malnutrition, representing an important risk factor of postoperative mortality and morbidity. Hence, the importance of finding effective nutritional interventions is crucial to improveovarian cancer patient‘s well-being and survival.MethodologyThis systematic review of randomized controlled trials (RCTs) aims at assessing the effects of nutritional interventions on clinical outcomes such as overall survival, progression-free survival, length of hospital stay (LOS), complications following surgery and/or chemotherapy in ovarian cancer patients.MethodsThree electronic bibliographic databases — MEDLINE, Web of Science and Cochrane Central Register of Controlled Trials - were used to conduct a systematic literature search based on fixed inclusion and exclusion criteria, until December 2018.ResultsA total of 14 studies were identified. Several early postoperative feeding interventions studies (n=8) were retrieved mainly demonstrating a reduction in LOS and an ameliorated intestinal recovery after surgery. Moreover, innovative nutritional approaches such as chewing gum intervention (n=1), coffee consumption (n=1), ketogenic diet intervention (n=2) or fruit and vegetable juice concentrate supplementation diet (n=1) and short-term fasting (n=1) have been shown as valid and well-tolerated nutritional strategies improving postoperative care.Conclusion despite an acceptable number of prospective trials, there is still a lack of homogeneous and robust endpoints. In particular, there is an urgent need ofRCTs evaluating overall survival and progression-free survival during ovarian oncology treatments. Further high-quality studies are warranted, especially prospective study and large RCTs, with more homogeneous types of intervention and clinical outcomes, including a more specific sampling of ovarian cancer women, to identify appropriate and effective nutritional strategies for this cancer at high risk of malnutrition.DisclosureNothing to disclose.